logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
A

Ashleigh R. Tuite

university of toronto

39H-index
245Paper Count
6.4KCitation Count
Published Papers 76
Publication Date
logo
Vaccination as cost-stabilizing health infrastructure: A Canadian perspective
errCANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE
IF2.6
err2026-06-16
err0
errOAAI
errAshleigh R. Tuite; David N. Fisman; Ellen Rafferty; Matthew Tunis
errShare
errSave
Assessing the spatial-temporal relationship between population factors and COVID-19 testing rates in the City of Toronto
errDiscover Social Science and Health
IF1.3
err2026-05-13
err0
PREAI
errAmoako, Afia; Carabali, Mabel; Ge, Erjia; Tuite, Ashleigh R.; Fisman, David N.
errShare
errSave
Cost-effectiveness of ongoing COVID-19 vaccination in the context of high population immunity: A structured review of international economic evidence
errVaccine
IF3.5
err2026-05-06
err0
errOAAI
errAshleigh R. Tuite; Nicole Forbes; Marina I. Salvadori; Matthew Tunis
errShare
errSave
Vaccine Performance Helps Explain Heterogeneity in Indirect Protection Across Influenza Vaccine Trials
errClinical Infectious Diseases
IF7.3
err2026-04-17
err0
errOAAI
errAshleigh R Tuite; Bryna F Warshawsky; Lindsay Friedman; Jeffrey C Kwong; David W Dick
errShare
errSave
Association between seasonal respiratory virus activity and invasive pneumococcal disease in central Ontario, Canada
errBMC Infectious Diseases
IF3
err2026-01-24
err0
PREAI
errSimmons, Alison E.; Berry, Isha; Buchan, Sarah A.; Tuite, Ashleigh R.; Fisman, David N.
errShare
errSave
Insights from a Ventilation-Aware Pandemic and Outbreak Risk Model (VAPOR)
errEpidemics
IF2.4
err2025-12-09
err0
errOAAI
errNatalie J. Wilson; Callandra Moore; Clara Eunyoung Lee; Ashleigh R. Tuite; David N. Fisman
errShare
errSave
Cost-utility analysis of current COVID-19 vaccination program recommendations in Canada
errvaccine
IF2.2
err2025-06-01
err0
errOAAI
errAlison E. Simmons; Rafael N. Miranda; Michael W.Z. Li; Gebremedhin B. Gebretekle; Min Xi; Marina I. Salvadori; Bryna Warshawsky; Eva Wong; Raphael Ximenes; Melissa K. Andrew; Sarah Wilson; Matthew Tunis; Ashleigh R. Tuite
errShare
errSave
Impact of adjustment for differential testing by age and sex on apparent epidemiology of SARS-CoV-2 infection in Ontario, Canada
errBMC INFECTIOUS DISEASES
IF3
err2025-04-23
err0
errOAAI
errBosco, Savana; Peng, Amy; Tuite, Ashleigh R.; Simmons, Alison; Fisman, David N.
errShare
errSave
Initial Effectiveness of mRNA-1273 Against SARS-CoV-2 Infection and Hospitalization in Young Children
errOPEN FORUM INFECTIOUS DISEASES
IF3.8
err2024-12-19
err0
errOAAI
errAglipay, Mary; Maguire, Jonathon L.; Swayze, Sarah; Tuite, Ashleigh; Mamdani, Muhammad; Keown-Stoneman, Charles; Birken, Catherine S.; Kwong, Jeffrey C.
errShare
errSave
Switching from a 2-dose to a 1-dose program of gender-neutral routine vaccination against human papillomavirus in Canada: a mathematical modelling analysis
errCANADIAN MEDICAL ASSOCIATION JOURNAL
IF11.3
err2024-10-06
err1
errOAAI
errDrolet, Melanie; Laprise, Jean-Francois; Chamberland, Eleonore; Sauvageau, Chantal; Wilson, Sarah; Lim, Gillian H.; Ogilvie, Gina; Tuite, Ashleigh; Brisson, Marc
errShare
errSave
Respiratory syncytial virus vaccination strategies for older Canadian adults: a cost-utility analysis
errCANADIAN MEDICAL ASSOCIATION JOURNAL
IF11.3
err2024-09-09
err0
errOAAI
errTuite, Ashleigh R.; Simmons, Alison E.; Rudd, Monica; Cernat, Alexandra; Gebretekle, Gebremedhin B.; Yeung, Man Wah; Killikelly, April; Siu, Winnie; Buchan, Sarah A.; Brousseau, Nicholas; Tunis, Matthew
errShare
errSave
Examining the effects of voluntary avoidance behaviour and policy-mediated behaviour change on the dynamics of SARS-CoV-2: A mathematical model
errINFECTIOUS DISEASE MODELLING
IF2.5
err2024-09-01
err1
errOAAI
errBrankston, Gabrielle; Fisman, David N.; Poljak, Zvonimir; Tuite, Ashleigh R.; Greer, Amy L.
errShare
errSave
Impact of community mask mandates on SARS-CoV-2 transmission in Ontario after adjustment for differential testing by age and sex
errPNAS NEXUS
IF3.8
err2024-02-12
err3
errOAAI
errPeng, Amy; Bosco, Savana; Simmons, Alison E.; Tuite, Ashleigh R.; Fisman, David N.
errShare
errSave
Diminished Neutralization Capacity of SARS-CoV-2 Omicron BA.1 in Donor Plasma Collected from January to March 2021
errMICROBIOLOGY SPECTRUM
IF3.8
err2023-08-17
err1
errOAAI
errLin, Yi-Chan J.; Evans, David H.; Robbins, Ninette F.; Orjuela, Guillermo; Abe, Kento T.; Rathod, Bhavisha; Colwill, Karen; Gingras, Anne-Claude; Tuite, Ashleigh; Yi, Qi-Long; O'Brien, Sheila F.; Drews, Steven J.
errShare
errSave
Estimated costs and quality-adjusted life-years lost due to N. gonorrhoeae infections acquired in 2015 in the United States: A modelling study of overall burden and disparities by age, race/ethnicity, and other factors
errLANCET REGIONAL HEALTH-AMERICAS
IF7.6
err2022-12-01
err3
errOAAI
errLi, Yunfei; Ronn, Minttu M.; Tuite, Ashleigh R.; Chesson, Harrell W.; Gift, Thomas L.; Trikalinos, Thomas A.; Testa, Christian; Bellerose, Meghan; Hsu, Katherine; Berruti, Andres A.; Malyuta, Yelena; Menzies, Nicolas A.; Salomon, Joshua A.
errShare
errSave
Utilization of the Abbott SARS-CoV-2 IgG II Quant Assay To Identify High-Titer Anti-SARS-CoV-2 Neutralizing Plasma against Wild-Type and Variant SARS-CoV-2 Viruses
errMICROBIOLOGY SPECTRUM
IF3.8
err2022-10-26
err7
errOAAI
errLin, Yi-Chan J.; Evans, David H.; Robbins, Ninette F.; Orjuela, Guillermo; Hu, Queenie; Samson, Reuben; Abe, Kento T.; Rathod, Bhavisha; Colwill, Karen; Gingras, Anne-Claude; Tuite, Ashleigh; Yi, Qi-Long; O'Brien, Sheila F.; Drews, Steven J.
errShare
errSave
Severity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Pregnancy in Ontario: A Matched Cohort Analysis
errCLINICAL INFECTIOUS DISEASES
IF7.3
err2022-08-19
err5
errOAAI
errMurison, Kiera R.; Grima, Alicia A.; Simmons, Alison E.; Tuite, Ashleigh R.; Fisman, David N.
errShare
errSave
Relative Virulence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Among Vaccinated and Unvaccinated Individuals Hospitalized With SARS-CoV-2
errCLINICAL INFECTIOUS DISEASES
IF7.3
err2022-07-01
err10
errOAAI
errGrima, Alicia A.; Murison, Kiera R.; Simmons, Alison E.; Tuite, Ashleigh R.; Fisman, David N.
errShare
errSave
A Qualitative Comparison of the Abbott SARS-CoV-2 IgG II Quant Assay against Commonly Used Canadian SARS-CoV-2 Enzyme Immunoassays in Blood Donor Retention Specimens, April 2020 to March 2021
errMICROBIOLOGY SPECTRUM
IF3.8
err2022-06-29
err5
errOAAI
errAbe, Kento T.; Rathod, Bhavisha; Colwill, Karen; Gingras, Anne-Claude; Tuite, Ashleigh; Robbins, Ninette F.; Orjuela, Guillermo; Jenkins, Craig; Conrod, Valerie; Yi, Qi-Long; O'Brien, Sheila F.; Drews, Steven J.
errShare
errSave
The authors respond to criticisms of their model parameters
errCANADIAN MEDICAL ASSOCIATION JOURNAL
IF11.3
err2022-06-19
err1
errOAAI
errFisman, David; Tuite, Ashleigh; Amoako, Afia
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
A
Anne‐Claude Gingras
H-index: 114 · Papers: 632
J
Joshua A. Salomon
H-index: 111 · Papers: 555
K
Karen S.L. Lam
H-index: 94 · Papers: 773
M
Muhammad Mamdani
H-index: 93 · Papers: 766
P
Philippe Gros
H-index: 91 · Papers: 406
View more